Development of potent aldose reductase inhibitors having a hydantoin structure
Authors:
- Ichitomo MiwaIMIchitomo Miwa
- Masuharu HiranoMHMasuharu Hirano
- Kazuhiro InagakiKIKazuhiro Inagaki
- Christophe Belbeoc'HCBChristophe Belbeoc'H
- Jun OkudaJOJun Okuda
- 1 September 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (17) , 2789-2794
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 15 references indexed in Scilit:
- Introduction: Evidence for the role of the polyol pathway in the pathophysiology of diabetic complicationsMetabolism, 1986
- Aldose reductase, glomerular metabolism, and diabetic nephropathyMetabolism, 1986
- Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complicationsJournal of Medicinal Chemistry, 1985
- The Pharmacology of Aldose Reductase InhibitorsAnnual Review of Pharmacology and Toxicology, 1985
- Effects of an aldose reductase inhibitor, 1-((p-bromophenyl)-sulfonyl)hydantoin, on cataract formation and tissue polyol levels in galactosemic rats.Chemical and Pharmaceutical Bulletin, 1985
- Hypoglycemic activity of aldose reductase inhibitor, 1-((p-bromophenyl)sulfonyl)hydantoin.Chemical and Pharmaceutical Bulletin, 1984
- Sorbitol, inositol and nerve conduction in diabetesLife Sciences, 1983
- Inhibition of aldose reductases from rat and bovine lenses by flavonoidsBiochemical Pharmacology, 1982
- Affinity purification and glucose specificity of aldose reductase from bovine lensArchives of Biochemistry and Biophysics, 1982
- Inhibition of aldose reductases from rat and bovine lenses by hydantoin derivatives.Chemical and Pharmaceutical Bulletin, 1982